1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports highly innovative translational research that provides a step-change improvement in therapy for Diffuse Midline Glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers and institutions focused on pediatric neuro-oncology. Confirm the full requirements in the official notice before applying.
Stand Up To Cancer – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge is funded by Stand Up To Cancer (SU2C) – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Pancreatic Cancer Research Program (PCARP) Patient-Centered Focus Area Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP), Department of Defense. This award supports the exploration and development of impactful and innovative concepts under a patient-centered focus that could ultimately lead to major advancements in patients' overall quality of life.
AACR-AstraZeneca Fellowship for Physician-Scientists for Digital Pathology and AI Training is sponsored by American Association for Cancer Research (AACR) and AstraZeneca. This fellowship supports the training and career development of pathologists with a strong interest in digital pathology, artificial intelligence, and/or computational pathology. It provides physician-scientists with integrated research experiences across academic and industry settings to gain practical experience in AI-driven cancer research and diagnostics. The program is intended to provide fellows with a comprehensive research experience that supports their scientific development and builds expertise in digital and computational pathology. Proposed research may be basic, translational, or clinical in nature and must be focused on digital and/or computational pathology. Applicants are required to complete two years of research training, consisting of one year at their academic institution and one year with their assigned AstraZeneca team.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read articleOn May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read article